SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 210 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $31,000 | -11.4% | 3,750 | 0.0% | 0.00% | – |
| Q3 2019 | $35,000 | -18.6% | 3,750 | -6.2% | 0.00% | – |
| Q2 2019 | $43,000 | -4.4% | 4,000 | -14.5% | 0.00% | – |
| Q1 2019 | $45,000 | +164.7% | 4,680 | +222.8% | 0.00% | – |
| Q4 2018 | $17,000 | -32.0% | 1,450 | 0.0% | 0.00% | – |
| Q3 2018 | $25,000 | +78.6% | 1,450 | +52.6% | 0.00% | – |
| Q2 2018 | $14,000 | -62.2% | 950 | -51.0% | 0.00% | -100.0% |
| Q1 2018 | $37,000 | +15.6% | 1,940 | 0.0% | 0.00% | – |
| Q4 2017 | $32,000 | +113.3% | 1,940 | +94.0% | 0.00% | – |
| Q3 2017 | $15,000 | +66.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $9,000 | +80.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |